Shusengoku: Shusengoku Company Articles of Association (revised in September 2024)
Shouxianggu 2024 Semi-Annual Results Conference Call Meeting Minutes
Shouxianggu\'s announcement on hosting the 2024 Investor Reception Day
Shousengoku\'s announcement on holding the 2024 semi-annual results briefing
Announcement of Resolutions of the 13th Meeting of the 4th Board of Supervisors of Shouxiangu
A special report on the storage and actual use of funds raised in the 2024 semi-annual period of Shousen Valley
Announcement of Resolutions of the 23rd Meeting of the 4th Board of Directors of Shouxianggu
Announcement of resolutions adopted at the 20th meeting of the fourth Board of Directors of Zhejiang Shouxiangu Pharmaceutical.
Legal Opinion on Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s differentiated dividend for the year 2023.
Announcement of holding the "Zhejiang Shouxiangu Pharmaceutical High-Quality Development Seminar and Investor Communication Meeting".
Announcement of Shouxiangu on attending the 2023 Shanghai Main Board Health Group Results Briefing
Shouxianggu's announcement on hosting the 2024 Investor Reception Day
Shouxianggu 2023 and 2024 First Quarter Results Exchange Conference Call Minutes
Evaluation report of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. on the performance of accounting firms in 2023
Announcement of Resolutions of the 12th Meeting of the 4th Board of Supervisors of Shouxiangu
Special report on the storage and actual use of funds raised in Shouxianggu in 2023
Announcement of Shouxianggu on applying for a comprehensive credit line for 2024 and related guarantee matters
Lixin Certified Public Accountants Audit Report on the 2023 Deposit and Use of Funds Raised in Shouxiangu
Lixin Certified Public Accountants on the 2023 Audit Report and Financial Statements of Shouxianggu
Guoxin Securities Co., Ltd.'s special inspection opinion on the deposit and use of funds raised by Zhejiang Shouxiangu Pharmaceutical Co., Ltd. in 2023
No Data
No Data